BTK and myocarditis: Kinase inhibitors, such as the Janus kinase and Bruton tyrosine kinase inhibitors, have shown promising therapeutic effects in other irAEs, such as immune-associated enteritis and myocarditis,[34] and have demonstrated synergistic antitumor effects with ICIs.